Presynaptic Dysfunction by Familial Factors in Parkinson Disease
Wongyoung Lee, Soulmee Koh, Soondo Hwang, Sung Hyun Kim
Int Neurourol J. 2018;22(Suppl 3):S115-121.   Published online 2018 Oct 31
Citations to this article as recorded by
  Crossref logo
Dopaminergic Axons: Key Recitalists in Parkinson’s Disease
Abhishek Kumar Mishra, Anubhuti Dixit
Neurochemical Research.2022; 47(2): 234.     CrossRef
Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway
Richard B Parsons, Altin Kocinaj, Gustavo Ruiz Pulido, Sarah A Prendergast, Anna E Parsons, Paul D Facey, Frank Hirth
Human Molecular Genetics.2022; 31(17): 2918.     CrossRef
Defining Specific Cell States of MPTP-Induced Parkinson’s Disease by Single-Nucleus RNA Sequencing
Yunxia Guo, Junjie Ma, Hao Huang, Jitao Xu, Chao Jiang, Kaiqiang Ye, Ning Chang, Qinyu Ge, Guangzhong Wang, Xiangwei Zhao
International Journal of Molecular Sciences.2022; 23(18): 10774.     CrossRef
Proteomic insights into synaptic signaling in the brain: the past, present and future
Yalan Xu, Xiuyue Song, Dong Wang, Yin Wang, Peifeng Li, Jing Li
Molecular Brain.2021;[Epub]     CrossRef
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies
Luca Magistrelli, Cristoforo Comi
Journal of Neuroimmune Pharmacology.2020; 15(1): 74.     CrossRef
Impaired Replenishment of Cortico-Striatal Synaptic Glutamate in Huntington’s Disease Mouse Model
Caodu Buren, Gaqi Tu, Lynn A. Raymond
Journal of Huntington's Disease.2020; 9(2): 149.     CrossRef
Understanding of Neurological Diseases
Chang-Ju Kim
International Neurourology Journal.2018; 22(Suppl 3): S103.     CrossRef